Home / Indicator library / Biotechnology and Medical Care / Icares (6612) overview
Icares (6612) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for Icares, on one pageIcares (6612) snapshot, key figures
Icares (6612): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 243 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→6612: common questions
What is 6612's P/E ratio?
6612 traded at a price-to-earnings ratio of 78.76x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 6612's dividend yield?
6612's cash dividend yield was 1.85% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.
How fast is 6612's revenue growing?
6612 reported 30.2% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 6612's price / earnings high or low right now?
6612's price / earnings is 78.76x, which is above its one-year median of 61.42x and sits at the 81st percentile of the 36.15–88.76x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Is 6612's dividend yield high or low right now?
6612's dividend yield is 1.85%, which is above its one-year median of 1.73% and sits at the 79th percentile of the 1.13–1.95% range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.